Nelfinavir slows progress of HER2-positive tumor cells

[News]

After screening more than 2,300 drugs for their ability to halt the growth of breast cancer cells, Johns Hopkins researchers have discovered that the anti-HIV drug nelfinavir slows the progress of HER2-positive tumor cells, even if they are resistant to other breast cancer drugs.

More... (http://www.news-medical.net/news/20121012/Nelfinavir-slows-progress-of-HER2-positive-tumor-cells.aspx)